Overview

Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
This is an open-label, randomized trial in relapsed refractory subjects with mantle cell lymphoma (MCL).
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Everolimus
Sirolimus